Next-Gen Flu Trials: Safe Vaccine Options for Cancer Patients
Next-gen flu trials are prioritizing cancer patients and other immunocompromised groups, with data-driven designs, regulatory convergence, and digital recruitment reshaping safe vaccine options and pediatric back-to-school research.
Robert Maxwell
Oct 09, 2025
influenza vaccine trials
cancer patient immunizations
maternal vaccine studies
immunocompromised vaccine safety
